Netris Pharma
PrivateLast Round
Grant
May 28, 2026
Total Funding Raised
$48.64M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Netris Pharma is a biotechnology company that develops anti-cancer therapeutic molecules designed to overcome resistance to oncology treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Netris Pharma Comparables
Compare Netris Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medannex Ltd | 81% | |
| Compugen Ltd. | 78% | |
| Alethia Biotherapeutics | 77% |
Netris Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 28, 2026 | ||||
| Series A Extension | Dec 19, 2023 | ||||
| Grant | Jan 19, 2023 | ||||
| Grant | Dec 16, 2021 | ||||
| Series A | Dec 23, 2020 |
Netris Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Eclosion Ventures | Series A |
| Eurostars SME programme | Grant |
| Wille Finance AG | Series A |
| Horizon Europe | Grant |
| Bpifrance | Series A |
| EIC Fund | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 33% MoM.
- Oct 19, 2025
Results for drug candidate NP137 to be presented at ESMO Congress 2025.
Netris Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Netris Pharma's valuation, stock price, and market status.
Is Netris Pharma a public or private company?
Netris Pharma is a private company.
What is the current stock price of Netris Pharma?
Netris Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is Netris Pharma worth (valuation)?
Valuation information for Netris Pharma is not publicly available.
Can I buy Netris Pharma stock?
Netris Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Netris Pharma's last funding round?
Netris Pharma's most recent funding round was Series A Extension on December 19, 2023.
Who are the main investors in Netris Pharma?
Key investors in Netris Pharma include EIC Fund.
Will Netris Pharma IPO soon?
No public IPO plans have been announced for Netris Pharma.
How can I track Netris Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Netris Pharma's secondary market activity and sign up for updates.